Treatments for metastatic castrate resistant prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Cell Line Rectum Stromal Cells Neoplastic Cells, Circulating Cell Nucleus

Organisms5

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic Mice, Inbred C57BL

Diseases33

Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Prostatic Hyperplasia Neoplasms, Hormone-Dependent Neoplasm Metastasis Adenocarcinoma Disease Progression Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Lung Neoplasms Carcinoma Ovarian Neoplasms Neoplasm Recurrence, Local Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Neovascularization, Pathologic Urinary Bladder Neoplasms Disease Models, Animal Colorectal Neoplasms Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction

Chemicals and Drugs73

Androgen Antagonists Receptors, Androgen Taxoids Prostate-Specific Antigen Androgens Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists RNA, Messenger Anilides Dihydrotestosterone Finasteride Metribolone RNA, Small Interfering Flutamide Anticarcinogenic Agents Cancer Vaccines Glutamate Carboxypeptidase II DNA, Neoplasm 5-alpha Reductase Inhibitors PTEN Phosphohydrolase Antineoplastic Agents, Phytogenic Testosterone Congeners Antigens, Neoplasm Androstenols Nitriles Testosterone Proto-Oncogene Proteins c-akt 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Phenylthiohydantoin Azasteroids Tumor Suppressor Protein p53 RNA, Neoplasm Transcription Factors Racemases and Epimerases MicroRNAs Tumor Suppressor Proteins Cholestenone 5 alpha-Reductase Estramustine Receptor, erbB-2 Leuprolide DNA-Binding Proteins Enzyme Inhibitors Antibodies, Monoclonal Goserelin Glutathione S-Transferase pi Proto-Oncogene Proteins c-bcl-2 Receptors, Estrogen DNA Primers Proto-Oncogene Proteins Paclitaxel Kallikreins Prostatic Secretory Proteins Androgen-Binding Protein Steroid 17-alpha-Hydroxylase Oncogene Proteins, Fusion Receptor, Epidermal Growth Factor Insulin-Like Growth Factor Binding Protein 3 Membrane Proteins Nuclear Proteins Anti-Bacterial Agents Carotenoids Cisplatin Protein Kinase Inhibitors Caspases Trans-Activators Protein-Serine-Threonine Kinases Ki-67 Antigen Plant Extracts Cadherins

Analytical, Diagnostic and Therapeutic Techniques and Equipment75

Orchiectomy Castration Prostatectomy Early Detection of Cancer Neoplasm Grading Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Prognosis Risk Factors Digital Rectal Examination Neoplasm Transplantation Transplantation, Heterologous Blotting, Western Immunohistochemistry Gene Expression Profiling Case-Control Studies Transurethral Resection of Prostate Risk Prospective Studies Follow-Up Studies Retrospective Studies Biopsy Survival Rate Sensitivity and Specificity Survival Analysis Risk Assessment Treatment Outcome Transfection Biopsy, Needle Odds Ratio Incidence Oligonucleotide Array Sequence Analysis Brachytherapy Cohort Studies Tumor Burden Polymerase Chain Reaction Combined Modality Therapy Disease-Free Survival Tissue Array Analysis Antineoplastic Combined Chemotherapy Protocols Drug Screening Assays, Antitumor SEER Program Multivariate Analysis Predictive Value of Tests Registries Radiotherapy Molecular Targeted Therapy Kaplan-Meier Estimate Logistic Models Reproducibility of Results Nomograms Radiotherapy Dosage Models, Biological Radiotherapy, Conformal Questionnaires Disease Models, Animal Flow Cytometry Gene Knockdown Techniques Mass Screening Clinical Trials as Topic Confidence Intervals Immunoenzyme Techniques In Situ Hybridization, Fluorescence Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Real-Time Polymerase Chain Reaction Immunotherapy Genetic Therapy ROC Curve Immunoblotting Chemotherapy, Adjuvant Microbial Sensitivity Tests Proportional Hazards Models Drug Administration Schedule

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes47

Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Genetic Predisposition to Disease Signal Transduction Cell Survival Risk Genotype Cell Growth Processes Down-Regulation Cell Division Mutation Sensitivity and Specificity Transfection Time Factors Odds Ratio Cell Movement Dose-Response Relationship, Drug Up-Regulation DNA Methylation Cell Cycle Promoter Regions, Genetic Polymorphism, Genetic Base Sequence Gene Silencing RNA Interference Nomograms Gene Fusion Gene Expression Drug Resistance Genes, Tumor Suppressor Chromosomes, Human, Pair 8 Phosphorylation Phenotype Alleles Drug Synergism Diet Transcription, Genetic Polymorphism, Single Nucleotide Genes, Neoplasm Germ-Line Mutation Radiation Tolerance Drug Resistance, Microbial Enzyme Activation Amino Acid Sequence Protein Binding

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science11

Survival Rate Incidence Molecular Sequence Data Base Sequence SEER Program Registries Radiotherapy, Conformal Questionnaires Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted Amino Acid Sequence

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care32

Risk Factors Watchful Waiting Case-Control Studies Risk Prospective Studies Follow-Up Studies Retrospective Studies Survival Rate Sensitivity and Specificity Survival Analysis Risk Assessment Treatment Outcome Odds Ratio Incidence Cohort Studies Disease-Free Survival National Cancer Institute (U.S.)Age Factors SEER Program Multivariate Analysis Predictive Value of Tests Registries Kaplan-Meier Estimate Logistic Models Reproducibility of Results Nomograms Questionnaires Mass Screening Clinical Trials as Topic Confidence Intervals ROC Curve Proportional Hazards Models

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Orchiectomy Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant Androgen Antagonists Receptors, Androgen Castration Taxoids Prostate Cell Line, Tumor Drug Resistance, Neoplasm Prostate-Specific Antigen Androgens Prostatectomy Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Neoplasms, Hormone-Dependent Early Detection of Cancer Mice, Nude Tumor Markers, Biological Neoplasm Metastasis Adenocarcinoma Disease Progression Prostatic Intraepithelial Neoplasia Tosyl Compounds Bone Neoplasms Tumor Cells, Cultured Neoplasm Invasiveness Apoptosis Antineoplastic Agents Cell Proliferation Neoplasm Grading Neoplasm Staging Antineoplastic Agents, Hormonal Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins Xenograft Model Antitumor Assays Androgen Receptor Antagonists Prognosis RNA, Messenger Risk Factors Digital Rectal Examination Anilides Neoplasm Transplantation Breast Neoplasms Watchful Waiting Dihydrotestosterone Transplantation, Heterologous Finasteride Blotting, Western Neoplasms Immunohistochemistry Gene Expression Profiling Signal Transduction Case-Control Studies Lung Neoplasms Carcinoma Metribolone Cell Survival Transurethral Resection of Prostate Risk Prospective Studies Genotype RNA, Small Interfering Cell Growth Processes Ovarian Neoplasms Follow-Up Studies Down-Regulation Neoplasm Recurrence, Local Cell Division Mutation Retrospective Studies Biopsy Survival Rate Sensitivity and Specificity Flutamide Survival Analysis Risk Assessment Anticarcinogenic Agents United States Cancer Vaccines Mice, SCID Treatment Outcome Colonic Neoplasms Glutamate Carboxypeptidase II DNA, Neoplasm Transfection Biopsy, Needle 5-alpha Reductase Inhibitors Time Factors PTEN Phosphohydrolase Odds Ratio Incidence Cell Movement Oligonucleotide Array Sequence Analysis Dose-Response Relationship, Drug Brachytherapy Cohort Studies Tumor Burden Up-Regulation

No FAQ available that match "treatments for metastatic castrate resistant prostate cancer"